BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Ankur Srivastava, Simcha Jong, Anna Gola, Ruth Gailer, Sarah Morgan, Karen Sennett, Sudeep Tanwar, Elena Pizzo, James O’Beirne, Emmanuel Tsochatzis, Julie Parkes, William Rosenberg. Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver diseaseBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1039-4
2
An-Hsun Chou, Ching-Chang Chen, Yu-Sheng Lin, Ming-Shyan Lin, Victor Chien-Chia Wu, Pei-Chi Ting, Shao-Wei Chen. A population-based analysis of endovascular aortic stent graft therapy in patients with liver cirrhosisJournal of Vascular Surgery 2019; 69(5): 1395 doi: 10.1016/j.jvs.2018.06.225
3
Elsebeth Elmstrøm Jensen, Rikke Baltzer, Susanne Helle Bjerg, Palle Bager. Supportive care in end-stage liver disease: a clinical reviewGastrointestinal Nursing 2018; 16(6): 38 doi: 10.12968/gasn.2018.16.6.38
4
Parham Safaie, Mugilan Poongkunran, Ping-Ping Kuang, Asad Javaid, Carl Jacobs, Rebecca Pohlmann, Imad Nasser, Daryl TY Lau. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinomaWorld Journal of Gastroenterology 2016; 22(12): 3404-3411 doi: 10.3748/wjg.v22.i12.3404
5
Behailu Terefe Tesfaye, Esayas Kebede Gudina, Dula Dessalegn Bosho, Teshale Ayele Mega, Chiara Lazzeri. Short-term clinical outcomes of patients admitted with chronic liver disease to selected teaching hospitals in EthiopiaPLOS ONE 2019; 14(8): e0221806 doi: 10.1371/journal.pone.0221806
6
Winston E. Abara, P. Spradling, Y. Zhong, A. Moorman, E. H. Teshale, L. Rupp, S. C. Gordon, M. Schmidt, J. A. Boscarino, Y. G. Daida, S. D. Holmberg. Hepatocellular Carcinoma Surveillance in a Cohort of Chronic Hepatitis C Virus-Infected Patients with CirrhosisJournal of Gastrointestinal Cancer 2020; 51(2): 461 doi: 10.1007/s12029-019-00255-4
7
Frank T. Spradley, Jillian A. Smith, Barbara T. Alexander, Christopher D. Anderson. Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal diseaseAmerican Journal of Physiology-Endocrinology and Metabolism 2018; 315(5): E795 doi: 10.1152/ajpendo.00394.2017
8
E. Lawitz, F. Poordad, J. A. Gutierrez, T. N. Kakuda, G. Picchio, G. Beets, A. Vandevoorde, P. Van Remoortere, B. Jacquemyn, D. Luo, S. Ouwerkerk-Mahadevan, L. Vijgen, V. Van Eygen, M. Beumont. Simeprevir, daclatasvir and sofosbuvir for hepatitis C virus-infected patients with decompensated liver diseaseJournal of Viral Hepatitis 2017; 24(4): 287 doi: 10.1111/jvh.12645
9
Gennaro D’Amico, Giovanni Perricone. Prediction of Decompensation in Patients with Compensated Cirrhosis: Does Etiology Matter?Current Hepatology Reports 2019; 18(2): 144 doi: 10.1007/s11901-019-00473-1
10
Eric Lawitz, Fred Poordad, Julio A. Gutierrez, Maria Beumont, Greet Beets, Ann Vandevoorde, Pieter Van Remoortere, Donghan Luo, Leen Vijgen, Veerle Van Eygen, Mohamed Gamil. Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus‐infected patients: Long‐term follow‐up results from the open‐label, Phase II IMPACT studyHealth Science Reports 2020; 3(2) doi: 10.1002/hsr2.145
11
Emma Nilsson, Harald Anderson, Konstantina Sargenti, Stefan Lindgren, Hanne Prytz. Clinical course and mortality by etiology of liver cirrhosis in Sweden: a population based, long-term follow-up study of 1317 patientsAlimentary Pharmacology & Therapeutics 2019; 49(11): 1421 doi: 10.1111/apt.15255
12
Jorge Simon, Alberto Ouro, Lolia Ala-Ibanibo, Natalia Presa, Teresa Cardoso Delgado, María Luz Martínez-Chantar. Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide TurnoverInternational Journal of Molecular Sciences 2019; 21(1): 40 doi: 10.3390/ijms21010040
13
Sehrish Kamal, Muhammad Ali Khan, Ankur Seth, George Cholankeril, Deepansh Gupta, Utkarsh Singh, Faisal Kamal, Colin W Howden, Christopher Stave, Satheesh Nair, Sanjaya K Satapathy, Aijaz Ahmed. Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-AnalysisAmerican Journal of Gastroenterology 2017; 112(10): 1495 doi: 10.1038/ajg.2017.170
14
Lindsay A Sobotka, Carleen Spitzer, Alice Hinton, Anthony Michaels, A James Hanje, Khalid Mumtaz, Lanla F Conteh. Management of hepatic hydrothorax and effect on length of stay, mortality, cost, and 30‐day hospital readmissionJournal of Gastroenterology and Hepatology 2020; 35(4): 641 doi: 10.1111/jgh.14842
15
Lindsay A Sobotka, Rohan M Modi, Akshay Vijayaraman, A James Hanje, Anthony J Michaels, Lanla F Conteh, Alice Hinton, Ashraf El-Hinnawi, Khalid Mumtaz. Paracentesis in cirrhotics is associated with increased risk of 30-day readmissionWorld Journal of Hepatology 2018; 10(6): 425-432 doi: 10.4254/wjh.v10.i6.425
16
Suzanna Fitzpatrick, Hazel Dhates Asunio Domingo, Sarah Merrill Finke. The Care of the Decompensated Cirrhotic PatientThe Journal for Nurse Practitioners 2017; 13(4): 256 doi: 10.1016/j.nurpra.2016.11.026